Skip to main content

Dr. Fubiao Niu received his PhD after defending his thesis “The roles of noncoding RNAs in B-cell lymphomas”

Dr. Fubiao Niu received his PhD after defending his thesis “The roles of noncoding RNAs in B-cell lymphomas”. Dr. Niu who worked in a team guided by Dr. Joost Kluiver and Prof. Anke van den Berg, will continue his scientific career as a postdoc in Bejing, China.


This entry was posted in Uncategorized by admin. Bookmark the permalink.

PhD candidate Johanna Veldman and Dr. Arjan Diepstra presented at the 2020 Interlymph virtual annual meeting.

PhD candidate Johanna Veldman and Dr. Arjan Diepstra presented at the 2020 Interlymph virtual annual meeting. Johanna Veldman presented on “Rosetting T-cells in Hodgkin Lymphoma”, and Dr. Diepstra presented on “Cell-type specific eQTL and HLA”.


This entry was posted in Uncategorized by admin. Bookmark the permalink.

Hematologist Dr. Tom van Meerten receives 30 million to set up a CAR T-cell facility in the UMCG

Hematologist Dr. Tom van Meerten receives 30 million to set up a CAR T-cell facility in the UMCG. The project is in close collaboration with the Radboud MC, Erasmus MC and the Amsterdam UMC. In Groningen, Rotterdam and Amsterdam patients will be treated with CAR T-cells generated in Groningen. For further reading see here and here (in Dutch).


This entry was posted in Uncategorized by admin. Bookmark the permalink.

Kickoff meeting of the H2020-TWINNING project

Kickoff meeting of the H2020-TWINNING project “ON THE ROAD TO EXCELLENCE IN UNRAVELLING THE (EPI)GENETIC LANDSCAPE OF HEMATOLOGIC NEOPLASMS” (http://www.nextlevel-h2020.eu/), a consortium between the Institute of Human Genetics (Poznań, Maciej Giefing), UGhent (Pieter van de Vlierberge), UULM (Reiner Siebert) and the LRG of the UMCG (Anke van den Berg, Lydia Visser en Joost Kluiver)


This entry was posted in Uncategorized by admin. Bookmark the permalink.